A recent drug combination screening for the treatment of diffuse large B-cell lymphoma (DLBCL).
A data frame with the following columns: BlockID, DrugRow, DrugCol, Row, Col, Response, Replicate, ConcRow, ConcCol, ConcUnit
Mathews Griner LA, Guha R, Shinn P, Young RM, Keller JM, et al. High-throughput combinatorial screening identifies drugs that cooperate with ibrutinib to kill activated B-cell-like diffuse large B-cell lymphoma cells. Proc Natl Acad Sci USA 2014; 111:2349-54.
Add the following code to your website.
For more information on customizing the embed code, read Embedding Snippets.